Prostaglandin E2 regulates amyloid precursor protein expression via the EP2 receptor in cultured rat microglia

Neuroscience Letters

Volumn 362, Issue 2, 2004, Pages 127-130

  Pooler, Amy M ^a   Arjona, Anibal A ^a   Lee, Robert K ^a   Wurtman, Richard J ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Alzheimer's disease; Amyloid; Cyclic AMP; Inflammation; Microglia; Prostaglandin

Indexed keywords

6 ISOPROPOXY 9 OXO 2 XANTHENECARBOXYLIC ACID; AMYLOID PRECURSOR PROTEIN; BUTAPROST; CYCLIC AMP; PROSTAGLANDIN E2; 6-ISOPROPOXY-9-OXOXANTHENE-2-CARBOXYLIC ACID; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN EP2 RECEPTOR; XANTHONE DERIVATIVE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; GENE CONTROL; GENE OVEREXPRESSION; MICROGLIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; ANIMAL; BIOSYNTHESIS; CELL CULTURE; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; GENE EXPRESSION REGULATION; METABOLISM; PHYSIOLOGY;

AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; CELLS, CULTURED; DINOPROSTONE; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION; MICROGLIA; RATS; RECEPTORS, PROSTAGLANDIN E; XANTHONES;

EID: 2942598274     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2004.03.013     Document Type: Article

References (22)

1. An S., Yang J., Xia M., Goetzl E.J. Cloning and expression of the EP2 subtype of human receptors for prostaglandin E2. Biochem. Biophys. Res. Commun. 197:1993;263-270
2. Caggiano A.O., Kraig R.P. Prostaglandin E receptor subtypes in cultured rat microglia and their role in reducing lipopolysaccharide-induced interleukin-1beta production. J. Neurochem. 72:1999;565-575
3. Esch F.S., Keim P.S., Beattie E.C., Blacher R.W., Culwell A.R., Oltersdorf T., McClure D., Ward P.J. Cleavage of amyloid beta peptide during constitutive processing of its precursor. Science. 248:1990;1122-1124
4. Fleminger S., Oliver D.L., Lovestone S., Rabe-Hesketh S., Giora A. Head injury as a risk factor for Alzheimer's disease: the evidence 10 years on; a partial replication. J. Neurol. Neurosurg. Psychiatry. 74:2003;857-862
5. Giulian D., Baker T.J. Characterization of ameboid microglia isolated from developing mammalian brain. J. Neurosci. 6:1986;2163-2178
6. Kumar A., La Rosa F.G., Hovland A.R., Cole W.C., Edwards-Prasad J., Prasad K.N. Adenosine 3′, 5′-cyclic monophosphate increases processing of amyloid precursor protein (APP) to beta-amyloid in neuroblastoma cells without changing APP levels or expression of APP mRNA. Neurochem. Res. 24:1999;1209-1215
7. Laflamme N., Rivest S. Effects of systemic immunogenic insults and circulating proinflammatory cytokines on the transcription of the inhibitory factor kappaB alpha within specific cellular populations of the rat brain. J. Neurochem. 73:1999;309-321
8. Lee R.K., Knapp S., Wurtman R.J. Prostaglandin E2 stimulates amyloid precursor protein gene expression: inhibition by immunosuppressants. J. Neurosci. 19:1999;940-947
9. Marambaud P., Chevallier N., Ancolio K., Checler F. Post-transcriptional contribution of a cAMP-dependent pathway to the formation of alpha- and beta/gamma-secretases-derived products of beta APP maturation in human cells expressing wild-type and Swedish mutated beta APP. Mol. Med. 4:1998;715-723
10. McCarthy K.D., de Vellis J. Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J. Cell Biol. 85:1980;890-902
11. Montine T.J., Sidell K.R., Crews B.C., Markesbery W.R., Marnett L.J., Roberts L.J. 2nd, Morrow J.D. Elevated CSF prostaglandin E2 levels in patients with probable AD. Neurology. 53:1999;1495-1498
12. Nicoll J.A., Roberts G.W., Graham D.I. Apolipoprotein E epsilon 4 allele is associated with deposition of amyloid beta-protein following head injury. Nat. Med. 1:1995;135-137
13. Overmyer M., Helisalmi S., Soininen H., Laakso M., Riekkinen P. Sr., Alafuzoff I. Reactive microglia in aging and dementia: an immunohistochemical study of postmortem human brain tissue. Acta Neuropathol. 97:1999;383-392
14. Pasinetti G.M., Aisen P.S. Cyclooxygenase-2 expression is increased in frontal cortex of Alzheimer's disease brain. Neuroscience. 87:1998;319-324
15. Raby C.A., Morganti-Kossmann M.C., Kossmann T., Stahel P.F., Watson M.D., Evans L.M., Mehta P.D., Spiegel K., Kuo Y.M., Roher A.E., Emmerling M.R. Traumatic brain injury increases beta-amyloid peptide 1-42 in cerebrospinal fluid. J. Neurochem. 71:1998;2505-2509
16. Rehmann H., Schwede F., Doskeland S.O., Wittinghofer A., Bos J.L. Ligand-mediated activation of the cAMP-responsive guanine nucleotide exchange factor Epac. J. Biol. Chem. 278:2003;38548-38556
17. Shohami E., Shapira Y., Yadid G., Reisfeld N., Yedgar S. Brain phospholipase A2 is activated after experimental closed head injury in the rat. J. Neurochem. 53:1989;1541-1546
18. Sisodia S.S., Koo E.H., Beyreuther K., Unterbeck A., Price D.L. Evidence that beta-amyloid protein in Alzheimer's disease is not derived by normal processing. Science. 248:1990;492-495
19. Sola C., Garcia-Ladona F.J., Mengod G., Probst A., Frey P., Palacios J.M. Increased levels of the Kunitz protease inhibitor-containing beta APP mRNAs in rat brain following neurotoxic damage. Brain Res. Mol. Brain Res. 1-2:1993;41-52
20. Staples K.J., Bergmann M., Tomita K., Houslay M.D., McPhee I., Barnes P.J., Giembycz M.A., Newton R. Adenosine 3′, 5′-cyclic monophosphate (cAMP)-dependent inhibition of IL-5 from human T lymphocytes is not mediated by the cAMP-dependent protein kinase A. J. Immunol. 167:2001;2074-2080
21. Stephenson D.T., Lemere C.A., Selkoe D.J., Clemens J.A. Cytosolic phospholipase A2 (cPLA2) immunoreactivity is elevated in Alzheimer's disease brain. Neurobiol. Dis. 3:1996;51-63
22. Uryu K., Laurer H., McIntosh T., Praticò D., Martinez D., Leight S., Lee V.M.-Y., Trojanowski J.Q. Repetitive mild brain trauma accelerates Aβ deposition, lipid peroxidation, and cognitive impairment in a transgenic mouse model of Alzheimer amyloidosis. J. Neurosci. 22:2002;446-454